U. of Minnesota sues Gilead
Thursday, September 1, 2016 - 19:11
in Mathematics & Economics
School says drugmaker’s hepatitis C compound sofosbuvir infringes its patent
School says drugmaker’s hepatitis C compound sofosbuvir infringes its patent